Baseline characteristics
| Characteristics | N = 9 |
|---|---|
| Age, median (range) | 59 year-old (44–73) |
| BRCA mutation status (germline mutation/wild type/unknown) | 1/7/1 |
| Tumor type | |
| OvCa (HGSOC/Clear cell/Mixed Mullerian/ Mixed Serous and Endometrioid) | 6 (2/2/1/1) |
| Platinum sensitivity in OvCa (sensitive/resistant) | 2/5 |
| Primary Peritoneal cancer (platinum-resistant) | 1 |
| Endometrial carcinoma (MSI low) | 1 |
| Triple Negative Breast Cancer | 1 |
| ECOG Performance Status (0/1/2) | 3/6/0 |
| Number of previous treatments, median (range) | 2 (2–6) |
| Prior PARPi (n) | 0 |
| Prior bevacizumab (n) | 2 |
Abbreviations: N number, OvCa ovarian cancer, HGSOC high-grade serous OvCa, MSI microsatellite instability, PARPi poly ADP ribose polymerase inhibitor